Morpurgo Emilio, Vitale Gary C, Galandiuk Susan, Kimberling Jennifer, Ziegler Craig, Polk Hiram C
Department of Surgery, University of Louisville School of Medicine and the Digestive Health Center, Louisville, Kentucky 40292, USA.
J Gastrointest Surg. 2004 Jul-Aug;8(5):559-64. doi: 10.1016/j.gassur.2004.03.001.
The aim of this study was to evaluate the clinical characteristics of patients with familial adenomatous polyposis (FAP) undergoing surgical treatment over a 10-year period and specifically to evaluate the incidence and clinical outcome of patients treated for duodenal adenomas. Patients with FAP who underwent surgical treatment for colonic polyposis at the University of Louisville from January 1992 to July 2002 were investigated. Surgical treatment included colectomy and ileal J-pouch-anal anastomosis (IPAA) or completion proctectomy with or without IPAA in those who had previously undergone subtotal colectomy elsewhere. All patients underwent screening gastroduodenoscopy at 3-year intervals beginning at the time of diagnosis or referral. Postoperative morbidity, mortality, and functional outcome were evaluated, as well as the occurrence of extracolonic manifestations and results of treatment for duodenal adenomas when required. Fifty-four patients were included in the study (mean age 28 +/- 2 years). Twenty-seven of them (50%) underwent colectomy and IPAA as the initial operation. Twenty-seven patients had previously undergone subtotal colectomy. Eight of these 27 patients had cancer in the rectum, of which three were T4 and one was T2N1 cancer. Twenty-two patients underwent a completion proctectomy and three required abdominoperineal resection. Twenty of the 54 patients developed duodenal adenomas. The mean age of diagnosis of duodenal disease was not significantly different from that of patients who were still free of duodenal polyps (40 +/- 11 vs. 34 +/- 12 years). Seven of these 20 patients underwent local excision of duodenal polyps (either endocopically or transduodenally); four of these patients developed recurrent disease. Six patients underwent pancreaticoduodenectomy for duodenal adenomas with severe dyplasia. These patients experienced an increased number of bowel movements, from five per day (range 4 to 8) to 10 per day (range 6 to 15). One patient required pouch excision and end ileostomy to control diarrhea. Our data demonstrate the following: (1) patients with FAP who have undergone prior subtotal colectomy and ileorectal anastomosis have a high risk of developing advanced cancer in the rectal stump; (2) duodenal adenomas are common in patients with FAP and may occur at an early age; (3) screening duodenoscopy should be initiated at the time of diagnosis of FAP; (4) local excision of duodenal adenomas is associated with a high risk of local recurrence; and (5) even though pancreaticoduodenectomy is the treatment of choice for advanced duodenal adenomas, this procedure may adversely affect pouch function in some patients.
本研究的目的是评估在10年期间接受手术治疗的家族性腺瘤性息肉病(FAP)患者的临床特征,特别是评估十二指肠腺瘤患者的发病率和临床结局。对1992年1月至2002年7月在路易斯维尔大学因结肠息肉病接受手术治疗的FAP患者进行了调查。手术治疗包括结肠切除术和回肠J袋肛管吻合术(IPAA),或对先前在其他地方接受过次全结肠切除术的患者进行全直肠切除术,可选择或不选择IPAA。所有患者从诊断或转诊时开始,每3年进行一次胃十二指肠镜筛查。评估术后发病率、死亡率和功能结局,以及结肠外表现的发生情况和必要时十二指肠腺瘤的治疗结果。54例患者纳入研究(平均年龄28±2岁)。其中27例(50%)最初接受了结肠切除术和IPAA。27例患者先前接受过次全结肠切除术。这27例患者中有8例直肠发生癌症,其中3例为T4期,1例为T2N1期癌症。22例患者接受了全直肠切除术,3例需要腹会阴联合切除术。54例患者中有20例发生十二指肠腺瘤。十二指肠疾病的平均诊断年龄与仍无十二指肠息肉的患者无显著差异(40±11岁对34±12岁)。这20例患者中有7例接受了十二指肠息肉局部切除术(内镜下或经十二指肠);其中4例患者疾病复发。6例患者因严重异型增生的十二指肠腺瘤接受了胰十二指肠切除术。这些患者排便次数增加,从每天5次(范围4至8次)增至每天10次(范围6至15次)。1例患者需要切除J袋并进行末端回肠造口术以控制腹泻。我们的数据表明:(1)先前接受过次全结肠切除术和回肠直肠吻合术的FAP患者,直肠残端发生进展期癌症的风险很高;(2)十二指肠腺瘤在FAP患者中很常见,且可能在早期发生;(3)FAP诊断时应开始进行十二指肠镜筛查;(4)十二指肠腺瘤局部切除术局部复发风险高;(5)尽管胰十二指肠切除术是晚期十二指肠腺瘤的首选治疗方法,但该手术可能对部分患者的J袋功能产生不利影响。